About
Kamau Therapeutics is a clinical-stage genome engineering company developing targeted gene integration therapies by editing or inserting functional genetic constructs into specific genomic locations within stem and immune cells to treat serious and life-threatening diseases.
Explore Kamau Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.